News

Hebron Technology won a bid on the design and implementation of an oil-free compressed air pipe project at a pharmaceutical production facility owned by Tianjin Chase Sun…
Read More...

AstraZeneca announced that its Bydureon phase IIIb/IV EXSCEL (EXenatide Study of Cardiovascular Event Lowering) trial top-line results and met its primary safety objective of…
Read More...

GB Sciences announced that its subsidiary, Growblox Life Sciences has filed a patent application for the treatment of chronic pain and heart therapies based on myrcene-containing…
Read More...

DNAnexus announced that AstraZeneca  has selected its secure cloud-based platform for CGR (Centre for Genomics Research). Financial terms of the collaboration were not disclosed. The…
Read More...

Atox Bio announced that Reltecimod (previously AB103) successfully completed pre-specified futility analysis in patients with Necrotizing Soft Tissue Infections and will continue…
Read More...

Tom Privette has joined Acurian as vice president and head of global business development. He will be responsible to lead the commercial efforts of company sales organization worldwide.…
Read More...

Debiopharm International SA and ImmunoGen announced that Debiopharm has acquired ImmunoGen's IMGN529/Debio 1562, a clinical-stage anti-CD37 ADC (antibody-drug conjugates) for the…
Read More...

Palladio Biosciences announced that it has acquired global rights to lixivaptan from Chiesi USA to  develop it for Polycystic Kidney Disease (PKD), an orphan kidney disease for which…
Read More...

CROS NT announced an extension of its partnership with Medidata to provide customers with Medidata’s next-gen EDC and RTSM systems. Under the partnership, CROS NT will offer its…
Read More...

Worldwide Clinical Trials has appointed Karen Nowatkoski as Vice President of Clinical Operations and Site Management. She will oversee and provide global management for the team of…
Read More...

Tekni-Plex announced that it has acquired the assets of BrunaSeals which will become part of Tri-Seal, Tekni-Plex’s global closure liners business unit. Tri-Seal senior VP and…
Read More...

AstraZeneca announced that it has signed an agreement with Recordati for the commercial rights of Seloken/Seloken ZOK and associated Logimax fixed-dose combination treatments in Europe.…
Read More...

Nektar Therapeutics announced that Takeda signed the research collaboration agreement with Nektar Therapeutics through its wholly-owned subsidiary, Millennium Pharmaceuticals to enter…
Read More...

PCI Biotech and RXi Pharmaceuticals announced that they are extending their preclinical research collaboration initiated on April 7, 2015. The preclinical research collaboration will…
Read More...

EMA (European Medicines Agency) has recommended to grant a marketing authorisation in the European Union (EU) for a new ATMP (advanced therapy medicinal product) to treat adult patients…
Read More...

The EMA (European Medicines Agency) has recommended grant for marketing authorisation in the European Union (EU) for Oxervate (cenegermin) to treat neurotrophic keratitis. Oxervate is a…
Read More...

Sanofi announced that the CHMP (Committee for Medicinal Products for Human Use) of the EMA (European Medicines Agency) recommended the use of Insulin lispro Sanofi (insulin lispro 100…
Read More...

Amgen announced that it has submitted the BLA (Biologics License Application) for Erenumab along with the data from pivotal studies in patients with episodic and chronic migraine to the…
Read More...

Astellas Pharma President and CEO, Yoshihiko Hatanaka announced that they have completed the acquisition of Ogeda SA (Ogeda) and now it has become a wholly owned subsidiary of Astellas…
Read More...

Pharmadax announced that U.S. FDA has approved the generic equivalent of Seroquel XR (quetiapine fumarate) ER tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg, launched by Pharmadex in…
Read More...